Both in Pharmaceuticals
Seaport Therapeutics vs Amphastar Pharmaceuticals
Over the past year SPTX returned −16.0% and AMPH returned +16.6%; their daily moves had a correlation of -0.23.
SPTX −16.0% AMPH +16.6%Growth of $1, one year, split-adjusted
| Metric | SPTX | AMPH |
|---|---|---|
| Price | $19.60 | $27.72 |
| Market cap | $1.05B | $1.18B |
| Today | −7.11% | +2.93% |
| 1 month | +3.4% | +9.3% |
| 6 months | — | +26.7% |
| Year to date | — | +3.5% |
| 1 year | — | +14.4% |
| Revenue growth (YoY) | — | +5.4% |
| Gross margin | — | 50.8% |
| Net margin | — | 16.5% |
| P/E (TTM) | — | 15.0× |
| Price / sales | — | 1.6× |
| Net cash | $273.3M | -$321.9M |
| Dividend yield | — | — |
| Volatility (60d) | — | 31.9% |
| Short % of float | 19.2% | 14.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).